Why Trusted By Clients
Led by former FDA investigators and compliance officers who have:
- Issued FDA 483s
- Evaluated firms' responses
- Drafted Warning Letters
- Made real enforcement decisions
Our team of former FDA investigators and compliance leaders brings real enforcement and inspection expertise to strengthen CGMP compliance, reinforce audits, and support robust QMS oversight.
- Advise based on firsthand regulatory enforcement experience — not interpretation or theory
- Deliver inspection-tested, regulator-ready solutions that withstand FDA and global agency scrutiny
Deep, proven experience in FDA 483 and Warning Letter responses and remediation
- Customized, hands-on execution embedded with client teams
- Global presence: U.S., Europe, and Asia Pacific
- Build durable and sustainable compliance systems that leads to approvals and commercial supply continuity
- Specialized focus on FDA compliance, cGMP, quality systems, and inspection readiness
End-to-End Regulatory & cGMP Expertise
From ANDA/NDA support and quality systems to FDA 483 and Warning Letter remediation, mock audits, and inspection readiness, we deliver integrated solutions across the entire product lifecycle — accelerating compliance and strengthening long‑term performance.
Tailored Support — Never One-Size-Fits-All
We customize every engagement to your products, processes, and risk profile.
We Turn compliance challenges Into Competitive and Sustainable Business Advantage.